Dennis Helling - Nov 3, 2023 Form 4 Insider Report for Tabula Rasa HealthCare, Inc. (TRHC)

Role: Director
Signature: /s/ Brian W. Adams
Stock symbol: TRHC
Transactions as of: Nov 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/14/2023, 08:50 PM
Previous filing: Jun 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TRHC	Common Stock	Disposed to Issuer		-82.7K	-73.75%		29.4K	Nov 3, 2023	Direct	F1
transaction	TRHC	Common Stock	Disposed to Issuer		-3.79K	-12.88%		25.6K	Nov 3, 2023	Direct	F2
transaction	TRHC	Common Stock	Disposed to Issuer		-25.6K	-100%		0	Nov 3, 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRHC	Stock Option (Right to Buy)	Disposed to Issuer	$0	-2.37K	-100%	$0.00^*	0	Nov 3, 2023	Common Stock	2.37K	$14.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dennis Helling is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 82,676 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $868,098, representing the product obtained by multiplying (x) aggregate number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).
F2	Upon the consummation of the Merger, pursuant to the Merger Agreement, 3,792 outstanding restricted stock units ("RSUs") were cancelled and converted into the right to receive a cash payment of $39,816, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSUs, by (y) the offer price ($10.50).
F3	Upon the consummation of the Merger, pursuant to the Merger Agreement, 25,641 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $269,230.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).
F4	Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 2,369 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $14.